Altman Biomedical Consulting

Altman Biomedical Consulting was an Australian private healthcare consulting company that appears to have operated as a small biomedical and clinical-trial-sponsoring entity rather than a drug-development biotech. Publicly accessible records identify the company as Altman Biomedical Consulting Pty Ltd, founded in 2006 in New South Wales, Australia. The company is associated with a completed 2009 Phase 4 comparative clinical trial in head lice evaluating marketed products including NeutraLice Lotion, NeutraLice Advance Solution, and Moov Head Lice Solution. There is no evidence of an active proprietary therapeutic pipeline, marketed drug portfolio, major partnerships, or platform technology. Australian business registry data indicate the ABN was cancelled effective June 30, 2018, suggesting the company is no longer active.